A carregar...
Metabolic Reprogramming—A New Era How to Prevent and Treat Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Has Begun
Allogeneic hematopoietic stem cell transplantation (HSCT) is the solitary therapeutic therapy for many types of hematological cancers. The benefits of this procedure are challenged by graft vs. host disease (GVHD), causing significant morbidity and mortality. Recent advances in the metabolomics fiel...
Na minha lista:
| Publicado no: | Front Pharmacol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7748087/ https://ncbi.nlm.nih.gov/pubmed/33343357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.588449 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|